Abstract:Long-chain fatty acids (LCFAs) are one of the main energy-supplying substances in the body. LCFAs with different lengths and saturations may have contrasting biological effects that exacerbate or alleviate progress against a variety of systemic disorders of lipid metabolism in organisms. Nonalcoholic fatty liver disease is characterized by chronic inflammation and steatosis, mainly caused by the ectopic accumulation of lipids in the liver, especially LCFAs. CD36 is a scavenger receptor that recognizes and mediates the transmembrane absorption of LCFAs and is expressed in a variety of cells throughout the body. In previous studies, our group found that 7-ketocholesteryl-9-carboxynonanoate (oxLig-1) has the biological effect of targeting CD36 to inhibit oxidized low-density lipoprotein lipotoxicity-induced lipid metabolism disorder; it has an ω-carboxyl physiologically active center and is structurally similar to LCFAs. However, the biological mechanism of oxLig-1 binding to CD36 and competing for binding to different types of LCFAs is still not clear. In this study, molecular docking and molecular dynamics simulation were utilized to simulate and analyze the binding activity between oxLig-1 and different types of LCFAs to CD36 and confirmed by the enzyme-linked immunosorbent assay (ELISA) method. Absorption, distribution, metabolism, excretion, and toxicity (ADMET) platform was applied to predict the drug-forming properties of oxLig-1, and HepG2 cells model of oleic acid and nonalcoholic fatty liver disease (NAFLD) model mice were validated to verify the biological protection of oxLig-1 on lipid lowering. The results showed that there was a co-binding site of LCFAs and oxLig-1 on CD36, and the binding driving forces were mainly hydrogen bonding and hydrophobic interactions. The binding abilities of polyunsaturated LCFAs, oxLig-1, monounsaturated LCFAs, and saturated LCFAs to CD36 showed a decreasing trend in this order. There was a similar decreasing trend in the stability of the molecular dynamics simulation. ELISA results similarly confirmed that the binding activity of oxLig-1 to CD36 was significantly higher than that of typical monounsaturated and saturated LCFAs. ADMET prediction results indicated that oxLig-1 had a good drug-forming property. HepG2 cells model of oleic acid and NAFLD model mice study results demonstrated the favorable lipid-lowering biological effects of oxLig-1. Therefore, oxLig-1 may have a protective effect by targeting CD36 to inhibit the excessive influx and deposition of lipotoxicity monounsaturated LCFAs and saturated LCFAs in hepatocytes.

Fatty Acid Translocase CD36／SR?B2 and Its Mediation in Transmembrane Transportation of Long?Chain Fatty Acids

Cellular Uptake, Metabolism and Sensing of Long-Chain Fatty Acids

Fatty acid mobilization from adipose tissue is mediated by CD36 posttranslational modifications and intracellular trafficking

CD36 and Its Role in Regulating the Tumor Microenvironment

Context-specific Fatty Acid Uptake is a Finely-Tuned Multi-Level Effort

Membrane Fatty Acid Transporters in Muscles and their Relationships

FAM134B Promotes Adipogenesis by Increasing Vesicular Activity in Porcine and 3T3-L1 Adipocytes.

CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis

AMPK facilitates intestinal long-chain fatty acid uptake by manipulating CD36 expression and translocation

Fatty Acids Modulate the Expression Levels of Key Proteins for Cholesterol Absorption in Caco-2 Monolayer

Long non-coding RNAs regulate fatty acid and cholesterol metabolism

Molecular Cloning, Characterization, and Expression Analysis of Fatty Acid Translocase (FAT/CD36) in the Pigeon (columba Livia Domestica).

CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate

The Biological Functions and Regulatory Mechanisms of Fatty Acid Binding Protein 5 in Various Diseases

Advance in the research on several nuclear receptors related to bile acid metabolism

Regulation of AMPK Activation by CD36 Links Fatty Acid Uptake to β-Oxidation

Dietary Fatty Acids in Gut Health: Absorption, Metabolism and Function.

Effect of Diacylglycerol Acyltransferase 2overexpression in 3T3-L1 is Associated to an Increase in Mono-Unsaturated Fatty Acid Accumulation

A new concept of cellular uptake and intracellular trafficking of long-chain fatty acids

Molecular Drug Simulation and Experimental Validation of the CD36 Receptor Competitively Binding to Long-Chain Fatty Acids by 7-Ketocholesteryl-9-carboxynonanoate

DHHC4 and DHHC5 Facilitate Fatty Acid Uptake by Palmitoylating and Targeting CD36 to the Plasma Membrane.